Top

Infectious Disease Testing Market in the US 2015-2019

Category : Diagnostic and Biotech  | Published Date : Jan-2016 | Pages : 66
enquire GET DISCOUNT
About infectious disease testing
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. 

Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes.

Technavios analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases: 

The market is segmented based on technology: 
Molecular diagnostic test
POCT
Immunodiagnostic test

The POCT for infectious disease is further segmented based on application: 
HIV
Respiratory
HAIs
Sexual health
Tropical diseases
Hepatitis

In addition, the market is segmented based on products: 
Equipment
Consumables

Technavios report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market.

Key vendors
Abbott Diagnostics
Alere
Beckman Coulter Diagnostics
Roche
Siemens Healthcare

Other prominent vendors
Abaxis
Acon Laboratories
Avioq
BD 
Bio-Rad Laboratories
Cavidi
Cepheid
Chembio Diagnostic Systems
Clarity Diagnostics
EMD Millipore
Epitope Diagnostic
Gold Standard Diagnostics
Hologic
Immunetics
InBios International
Life Technologies 
Maxim Biomedical
Mindray
OraSure Technologies
Ortho Clinical Diagnostics
Quidel Corporation
Thermo Fisher Scientific 
Trinity Biotech 

Market driver
North America free trade agreement 
For a full, detailed list, view our report

Market challenge
Medical device excise tax law
For a full, detailed list, view our report

Market trend
Development of innovative diagnostics initiatives
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
PART 06: Infectious disease landscape in the US
Reimbursement in US
Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration
Five forces analysis
PART 07: Market segmentation by technology
Molecular diagnostic test
POCT for infectious diseases
Immunodiagnostic tests
PART 08: Market segmentation by application
PART 09: Market segmentation by product
Equipment
Consumables
PART 10: Market drivers
NAFTA
Demand for rapid and automated diagnostics
Shift toward patient-centered model
Focus on disease management
PART 11: Impact of drivers
PART 12: Market challenges
Medical device excise tax law
Increase in globalization
New microbial diseases
PART 13: Impact of drivers and challenges
PART 14: Market trends
Development of innovative diagnostics initiatives
Key role of US Army Medical Research Institute in Diagnostics and Development (USAMRIID)
Low-cost microfluidic devices for POCT
Focus on early diagnosis of infectious diseases
PART 15: Vendor landscape
Competitive scenario
Abbott Diagnostics
Alere
Roche Diagnostics
Siemens Healthcare
Beckman Coulter Diagnostics
Other prominent vendors
PART 16: Key vendor analysis
Abbott Diagnostics
Alere
Beckman Coulter
Roche Diagnostics
Siemens Healthcare
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Infectious disease testing market in US 2014-2019 ($ billions)
Exhibit 03: Average Medicare payments for infectious diseases
Exhibit 04: Five forces analysis
Exhibit 05: Segmentation of infectious disease testing market in US based on technology
Exhibit 06: Molecular diagnostic testing market in US 2014-2019 ($ billions)
Exhibit 07: POCT diagnostic testing market for infectious diseases in US 2014-2019 ($ billions)
Exhibit 08: Immunodiagnostic tests for infectious disease market in US 2014-2019 ($ billions)
Exhibit 09: Segmentation of infectious disease market in US by technology 2014
Exhibit 10: POCT for infectious diseases market in US by application
Exhibit 11: Segmentation of POCT for infectious disease market in US 2014
Exhibit 12: Infectious disease testing market in US by product
Exhibit 13: Segmentation of infectious disease testing market in US by product 2014
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Key Takeaways: Abbott Diagnostics
Exhibit 17: Key takeaways: Alere
Exhibit 18: Key takeaways: Roche Diagnostics
Exhibit 19: Key takeaways: Siemens Healthcare
Exhibit 20: Key takeaways: Beckman Coulter Diagnostics
Exhibit 21: Abbott Diagnostics: Key business offerings
Exhibit 22: Alere: Business segmentation by revenue 2014
Exhibit 23: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 24: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 25: Beckman Coulter: Business segmentation
Exhibit 26: Roche Diagnostics: Business segmentation by revenue 2014
Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 28: Roche Diagnostics: Segmentation of revenue by regions 2014
Exhibit 29: Siemens Healthcare: Business segmentation
Exhibit 30: Siemens Healthcare: Segmentation of revenue by geography 2014
...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Five User: US $ 3000
Site User: US $ 4000
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top